Articles
Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential
Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel.
Over their development...
Press Releases
Aptar’s Nasal Unidose Device Approved by US FDA for First Needle-Free Rescue Treatment for Severe Hypoglycemia
AptarGroup, Inc. , a global leader in dispensing and drug delivery solutions, announced that its Unidose Powder System was recently approved by the U.S....
Packaging & Labelling
Clariant Adds Pharmaceutical Desiccant Packet Production Capability in Cuddalore, India
The Clariant Healthcare Packaging business unit is now producing desiccant packets at its plant in Cuddalore, Tamil Nadu, India. The addition expands the range...
Press Releases
MedPharm Expands Relationship With Novan On Formulation Science
MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with biopharmaceutical company Novan Inc.
MedPharm has previously supported Novan by...
Press Releases
Boehringer Ingelheim Expands Idiopathic Pulmonary Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge...
Clinical Trials
Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for...
Clinical Trials
Carolina Partners Clinical Research Institute, LLC, Announces Partnership to Provide Research as Care
Carolina Partners Clinical Research Institute, LLC, North Carolina’s largest outpatient mental and behavioral health practice, has partnered with Elligo Health Research, a healthcare-enabling research...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read